García-Agudo Lidia, Jesús de la Calle Iría, Román Enry Manuela, Aznar Marín Pilar, Rodríguez-Iglesias Manuel
Hospital Universitario de Puerto Real, Cádiz, España.
Ginecol Obstet Mex. 2013 Apr;81(4):195-200.
Vaginal infections lie among the most common causes women ask for medical advice. In order of frequency bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis are responsible for 90% of vaginitis/vaginosis.
To evaluate a DNA hybridization test for simultaneous molecular detection of Gardnerella vaginalis, Candida species and Trichomonas vaginalis, as an alternative to conventional microbiological methods.
Cohort, cross-sectional, and comparative study of 1,003 vaginal samples from symptomatic women from our health-care area. Two swabs were obtained from each woman, one for routine microbiological diagnosis of vaginal infection (wet mount, Gram stain, and mycological culture) and the other for the DNA hybridization test (Affirm VPIII, Becton Dickinson). This method detects clinically significant levels of G. vaginalis (2 x 10(5) CFU/ml), Candida spp. (1 x 10(4) cells) and T. vaginalis (5x103 trichomonads).
Out of the 1,003 women studied, 30.6% tested positive for bacterial vaginosis, 23.3% for vulvovaginal candidiasis, and 0.5% for trichomoniasis. The Affirm VPIII method turned out positive in 27.5%, 27.4% and 0.5% of cases, respectively. No statistically significant differences were found between the molecular technique and conventional methods for microbiological diagnosis of vaginitis/ vaginosis (p < 0.05).
The Affirm VPIII test correlated well with wet mount, Gram stain and mycological culture. Although its cost is relatively high, it is fast, reproducible, easy, and can be done in either clinical laboratories or Gynecology offices, which permits prescribing a specific early treatment.
阴道感染是女性寻求医疗建议的最常见原因之一。按发生频率排序,细菌性阴道病、外阴阴道假丝酵母菌病和滴虫性阴道炎占阴道炎/阴道病的90%。
评估一种DNA杂交试验,用于同时分子检测阴道加德纳菌、念珠菌属和阴道毛滴虫,作为传统微生物学方法的替代方法。
对来自我们医疗保健区域有症状女性的1003份阴道样本进行队列、横断面和比较研究。从每位女性获取两份拭子,一份用于阴道感染的常规微生物学诊断(湿片法、革兰氏染色和真菌培养),另一份用于DNA杂交试验(Affirm VPIII,BD公司)。该方法可检测出具有临床意义水平的阴道加德纳菌(2×10⁵CFU/ml)、念珠菌属(1×10⁴个细胞)和阴道毛滴虫(5×10³个滴虫)。
在研究的1003名女性中,30.6%的细菌性阴道病检测呈阳性,23.3%的外阴阴道假丝酵母菌病检测呈阳性,0.5%的滴虫性阴道炎检测呈阳性。Affirm VPIII方法在病例中的阳性率分别为27.�%、27.4%和0.5%。在阴道炎/阴道病的微生物学诊断中,分子技术与传统方法之间未发现统计学上的显著差异(p<0.05)。
Affirm VPIII试验与湿片法、革兰氏染色和真菌培养相关性良好。尽管其成本相对较高,但它快速、可重复、操作简便,可在临床实验室或妇科门诊进行,这有助于进行早期特异性治疗。